Rothschild & Co Asset Management US’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-222,045
| Closed | -$10.5M | – | 301 |
|
|
2020
Q3 | $10.5M | Sell |
222,045
-47,615
| -18% | -$2.26M | 0.19% | 188 |
|
|
2020
Q2 | $15.9M | Sell |
269,660
-74,367
| -22% | -$4.38M | 0.23% | 169 |
|
|
2020
Q1 | $16.3M | Sell |
344,027
-30,341
| -8% | -$1.43M | 0.25% | 151 |
|
|
2019
Q4 | $22.6M | Buy |
374,368
+127,346
| +52% | +$7.69M | 0.24% | 179 |
|
|
2019
Q3 | $14.8M | Sell |
247,022
-5,519
| -2% | -$331K | 0.16% | 218 |
|
|
2019
Q2 | $16.2M | Sell |
252,541
-34,735
| -12% | -$2.23M | 0.17% | 209 |
|
|
2019
Q1 | $23.3M | Buy |
287,276
+13,184
| +5% | +$1.07M | 0.25% | 158 |
|
|
2018
Q4 | $14.8M | Sell |
274,092
-1,829
| -0.7% | -$98.9K | 0.18% | 204 |
|
|
2018
Q3 | $14.2M | Sell |
275,921
-7,079
| -3% | -$365K | 0.15% | 234 |
|
|
2018
Q2 | $11.8M | Buy |
283,000
+2,449
| +0.9% | +$102K | 0.13% | 257 |
|
|
2018
Q1 | $12.4M | Sell |
280,551
-2,626
| -0.9% | -$116K | 0.14% | 233 |
|
|
2017
Q4 | $14.2M | Buy |
283,177
+2,109
| +0.8% | +$106K | 0.15% | 223 |
|
|
2017
Q3 | $14.3M | Buy |
281,068
+27,426
| +11% | +$1.39M | 0.16% | 209 |
|
|
2017
Q2 | $12.9M | Buy |
253,642
+13,520
| +6% | +$688K | 0.15% | 223 |
|
|
2017
Q1 | $9.65M | Buy |
240,122
+18,587
| +8% | +$747K | 0.11% | 245 |
|
|
2016
Q4 | $10.6M | Buy |
221,535
+16,188
| +8% | +$774K | 0.13% | 229 |
|
|
2016
Q3 | $7.52M | Buy |
205,347
+15,353
| +8% | +$563K | 0.13% | 243 |
|
|
2016
Q2 | $4.43M | Buy |
189,994
+32,936
| +21% | +$767K | 0.08% | 278 |
|
|
2016
Q1 | $6.36M | Buy |
+157,058
| New | +$6.36M | 0.12% | 237 |
|
|
2015
Q4 | – | Sell |
-5,486
| Closed | -$222K | – | 522 |
|
|
2015
Q3 | $222K | Hold |
5,486
| – | – | ﹤0.01% | 339 |
|
|
2015
Q2 | $316K | Buy |
+5,486
| New | +$316K | 0.01% | 333 |
|